Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial

Contraception

Volumn 74, Issue 6, 2006, Pages 458-462

  Schreiber, Courtney A ^a   Creinin, Mitchell D ^a   Reeves, Matthew F ^a   Harwood, Bryna J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Early pregnancy failure; Mifepristone; Misoprostol; Spontaneous abortion

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; BLEEDING; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EVALUATION AND FOLLOW UP; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; NAUSEA; PAIN; PILOT STUDY; PREGNANCY DISORDER; REPEATED DRUG DOSE; SINGLE DRUG DOSE; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VOMITING;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; ADOLESCENT; ADULT; FEMALE; FETAL DEATH; HUMANS; MIFEPRISTONE; MISOPROSTOL; PATIENT SATISFACTION; PILOT PROJECTS; PREGNANCY; TREATMENT OUTCOME;

EID: 33845942261     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.07.007     Document Type: Article

References (20)

1. Warburton D., and Fraser F.C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Hum Genet 16 (1964) 1-25
2. Goldberg A.B., Greenberg M.B., and Darney P.D. Misoprostol and pregnancy. N Engl J Med 344 (2001) 38-47
3. Zhang J., Gilles J.M., Barnhart K.B., Creinin M.D., Westhoff C., and Frederick M.M. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 353 (2005) 761-769
4. Kulier R., Gulmezoglu A.M., Hofmeyr G.J., Cheng L.N., and Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 1 (2004) CD002855
5. Schaff E.A., Fielding S.L., Westhoff C., et al. Randomized trial of vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion (<56 days gestation). JAMA 284 (2000) 1948-1953
6. Schaff E.A., Fielding S.L., and Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 64 (2001) 81-85
7. Creinin M.D., Fox M.C., Teal S., et al. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103 (2004) 851-859
8. Nielsen S., Hahlin M., and Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynecol 106 (1999) 804-807
9. Coughlin L.B., Roberts D., Haddad N.G., and Long A. Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?. J Obstet Gynaecol 24 (2004) 69-71
10. Wagaarachchi P.T., Ashok P.W., Smith N.C., and Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Hum Reprod 16 (2001) 1849-1853
11. Gronlund A., Gronlund L., Clevin L., Anderson B., Palmgren N., and Lidegaard O. Management of missed abortion: comparison of medical treatment with either mifepristone and misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen County, Denmark. Acta Obstet Gynecol Scand 81 (2002) 1060-1065
12. Chia K.V., and Ogbo V.I. Medical termination of missed abortion. J Obstet Gynaecol 22 (2002) 184-186
13. Hermann W.L., Schlindler A.M., Wyss R., and Bischoff P. Effects of antiprogesterone RU 486 in early pregnancy and during the menstrual cycle. In: Beaulieu E.E., and Siegel S. (Eds). The antiprogestin steroid RU 486 and human fertility control (1985), Plenum, New York 259-262
14. Mahajan D.K., and London S.N. Mifepristone (RU486): a review. Fertil Steril 86 (1997) 967-976
15. El-Rafaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332 (1995) 983-987
16. Creinin M.D., and Darney P.D. Methotrexate and misoprostol for early abortion. Contraception 48 (1993) 339-348
17. Flaherty S.A. Pain measurement tools for clinical practice and research. AANAJ 63 (1996) 133-140
18. Rossi B., Creinin M.D., and Meyn L.A. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception 70 (2004) 313-317
19. Henshaw S.K. Unintended pregnancy in the United States. Fam Plann Perspect 30 (1998) 24-29
20. Creinin M.D., Shore E., Balusubramanian B., and Harwood B. The true cost differential between mifepristone and misoprostol compared to misoprostol alone for medical abortion. Contraception 71 (2005) 26-30